These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 16235062
1. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Gan IM, Ugahary LC, van Dissel JT, Feron E, Peperkamp E, Veckeneer M, Mulder PG, Platenkamp GJ, van Meurs JC. Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1200-5. PubMed ID: 16235062 [Abstract] [Full Text] [Related]
2. A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Manning S, Ugahary LC, Lindstedt EW, Wubbels RJ, van Dissel JT, Jansen JTG, Gan I, van Goor AT, Bennebroek CA, van der Werf DJ, Ossewaarde-van Norel A, Mayland Nielsen CC, Tilanus M, van den Biesen PR, Schellekens PA, La Heij E, Faridpooya K, van Overdam K, Veckeneer M, van Meurs JC. Acta Ophthalmol; 2018 Jun; 96(4):348-355. PubMed ID: 29214740 [Abstract] [Full Text] [Related]
3. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial. Albrecht E, Richards JC, Pollock T, Cook C, Myers L. Br J Ophthalmol; 2011 Oct; 95(10):1385-8. PubMed ID: 21289020 [Abstract] [Full Text] [Related]
4. Effect of intravitreal dexamethasone on vitreous vancomycin concentrations in patients with suspected postoperative bacterial endophthalmitis. Gan IM, Ugahary LC, van Dissel JT, van Meurs JC. Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1186-9. PubMed ID: 15906066 [Abstract] [Full Text] [Related]
5. A prospective multicenter randomized placebo-controlled trial of dexamethasone as an adjuvant in the treatment of postoperative bacterial endophthalmitis: interim safety analysis of the study drug and analysis of overall treatment results. Lindstedt EW, Bennebroek CA, van der Werf DJ, Veckeneer M, Norel AO, Nielsen CC, Wubbels RJ, van Dissel JT, van Meurs JC. Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1631-7. PubMed ID: 25107542 [Abstract] [Full Text] [Related]
12. Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Gan IM, van Dissel JT, Beekhuis WH, Swart W, van Meurs JC. Br J Ophthalmol; 2001 Nov; 85(11):1289-93. PubMed ID: 11673290 [Abstract] [Full Text] [Related]
13. Endophthalmitis After Clear Corneal Cataract Surgery: Outcomes Over Two Decades. Yannuzzi NA, Si N, Relhan N, Kuriyan AE, Albini TA, Berrocal AM, Davis JL, Smiddy WE, Townsend J, Miller D, Flynn HW. Am J Ophthalmol; 2017 Feb; 174():155-159. PubMed ID: 27889501 [Abstract] [Full Text] [Related]
14. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Lalwani GA, Flynn HW, Scott IU, Quinn CM, Berrocal AM, Davis JL, Murray TG, Smiddy WE, Miller D. Ophthalmology; 2008 Mar; 115(3):473-6. PubMed ID: 18067969 [Abstract] [Full Text] [Related]
20. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Liu SM, Way T, Rodrigues M, Steidl SM. Arch Ophthalmol; 2000 Jun; 118(6):803-6. PubMed ID: 10865318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]